C-reactive protein concentration predicts mortality in type 2 diabetes: the Diabetes Heart Study

This study documents the utility of C-reactive protein in predicting risk for all-cause mortality in European Americans with Type 2 diabetes and supports its use as a screening tool in risk prediction models (Diabetic Medicine)